Circulation Research. 2004;94:e27-e31
Published online before print January 29, 2004, doi: 10.1161/01.RES.0000119921.86460.37
Published online before print January 29, 2004, doi: 10.1161/01.RES.0000119921.86460.37
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2004 American Heart Association, Inc.
UltraRapid Communications |
Selective Suppression of Endothelial Cell Apoptosis by the High Molecular Weight Form of Adiponectin
From the Department of Internal Medicine and Molecular Science (H.K., S.K., M.K., T.F., Y.M.), Graduate School of Medicine, Osaka University, Osaka, Japan; Molecular Cardiology/Whitaker Cardiovascular Institute (N.O., K.W.), Boston University School of Medicine, Boston, Mass; Lead Discovery Research Laboratories (Y.A.), Sankyo Co Ltd, Tokyo, Japan.
Correspondence to Noriyuki Ouchi, MD, PhD, Molecular Cardiology/Whitaker Cardiovascular Institute, Boston University School of Medicine, 715 Albany St, W611, Boston, MA 02118. E-mail nouchi{at}bu.edu
Adiponectin is an adipocyte-derived, antiatherogenic protein that is present in serum as three isoforms. Total adiponectin levels are decreased in obese or diabetic humans or animal models. This study was designed to elucidate the relative isoform distribution of adiponectin in human disease states and identify the active form of adiponectin toward vascular endothelial cells. The percentage of high molecular weight form (HMW) per total adiponectin was significantly lower in patients with coronary artery disease than control subjects, whereas the hexamer form was similar and the trimer form was significantly higher. During weight reduction in obese subjects, the HMW form increased and the trimer and hexamer forms decreased. Recombinant adiponectin dose-dependently suppressed apoptosis and caspase-3 activity in human umbilical vein endothelial cells (HUVECs). Transduction with dominant-negative AMP-activated protein kinase (AMPK) abolished the suppressive effect of adiponectin on HUVECs. Gel filtration chromatography was used to separate the adiponectin isoforms, and the antiapoptotic effect toward HUVECs was only observed with the HMW form. These data suggest that HMW adiponectin specifically confers the vascular-protective activities of this adipocytokine. The full text of this article is available online at http://circres.ahajournals.org.
Key Words: atherosclerosis • apoptosis • adiponectin • endothelial cells • AMP-activated protein kinase
This article has been cited by other articles:
 |
|
 |
|
  M. Li, D. H. Kim, P. L. Tsenovoy, S. J. Peterson, R. Rezzani, L. F. Rodella, W. S. Aronow, S. Ikehara, and N. G. Abraham Treatment of Obese Diabetic Mice With a Heme Oxygenase Inducer Reduces Visceral and Subcutaneous Adiposity, Increases Adiponectin Levels, and Improves Insulin Sensitivity and Glucose Tolerance Diabetes, June 1, 2008; 57(6): 1526 - 1535. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Mahadev, X. Wu, S. Donnelly, R. Ouedraogo, A. D. Eckhart, and B. J. Goldstein Adiponectin inhibits vascular endothelial growth factor-induced migration of human coronary artery endothelial cells Cardiovasc Res, May 1, 2008; 78(2): 376 - 384. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Polak, Z Kovacova, C Holst, C Verdich, A Astrup, E Blaak, K Patel, J M Oppert, D Langin, J A Martinez, et al. Total adiponectin and adiponectin multimeric complexes in relation to weight loss-induced improvements in insulin sensitivity in obese women: the NUGENOB study. Eur. J. Endocrinol., April 1, 2008; 158(4): 533 - 541. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. T. Gonon, U. Widegren, A. Bulhak, F. Salehzadeh, J. Persson, P.-O. Sjoquist, and J. Pernow Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide Cardiovasc Res, April 1, 2008; 78(1): 116 - 122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Fasshauer, T. Waldeyer, J. Seeger, S. Schrey, T. Ebert, J. Kratzsch, U. Lossner, M. Bluher, M. Stumvoll, R. Faber, et al. Circulating high-molecular-weight adiponectin is upregulated in preeclampsia and is related to insulin sensitivity and renal function Eur. J. Endocrinol., February 1, 2008; 158(2): 197 - 201. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Shinmura, K. Tamaki, K. Saito, Y. Nakano, T. Tobe, and R. Bolli Cardioprotective Effects of Short-Term Caloric Restriction Are Mediated by Adiponectin via Activation of AMP-Activated Protein Kinase Circulation, December 11, 2007; 116(24): 2809 - 2817. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Wu, K. Mahadev, L. Fuchsel, R. Ouedraogo, S.-q. Xu, and B. J. Goldstein Adiponectin suppresses I{kappa}B kinase activation induced by tumor necrosis factor-{alpha} or high glucose in endothelial cells: role of cAMP and AMP kinase signaling Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1836 - E1844. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. K. Sinha, T. Songer, Q. Xiao, J. H. Sloan, J. Wang, S. Ji, W. E. Alborn, R. A. Davis, M. M. Swarbrick, K. L. Stanhope, et al. Analytical Validation and Biological Evaluation of a High Molecular-Weight Adiponectin ELISA Clin. Chem., December 1, 2007; 53(12): 2144 - 2151. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Hattori and Y. Nakano Response to Comment on: Goldstein et al. (2007) Globular Adiponectin Activates Nuclear Factor-{kappa}B and Activating Protein-1 and Enhances Angiotensin II-Induced Proliferation in Cardiac Fibroblasts: Diabetes 56:804-808 Diabetes, July 1, 2007; 56(7): e9 - e10. [Full Text] [PDF]
|
|
|
|
|
|
R. Shibata, K. Sato, M. Kumada, Y. Izumiya, M. Sonoda, S. Kihara, N. Ouchi, and K. Walsh Adiponectin accumulates in myocardial tissue that has been damaged by ischemia-reperfusion injury via leakage from the vascular compartment Cardiovasc Res, June 1, 2007; 74(3): 471 - 479. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. K.Y. Cheng, K. S.L. Lam, Y. Wang, Y. Huang, D. Carling, D. Wu, C. Wong, and A. Xu Adiponectin-Induced Endothelial Nitric Oxide Synthase Activation and Nitric Oxide Production Are Mediated by APPL1 in Endothelial Cells Diabetes, May 1, 2007; 56(5): 1387 - 1394. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. B. Bokko, L. Francione, E. Bandala-Sanchez, A. U. Ahmed, S. J. Annesley, X. Huang, T. Khurana, A. R. Kimmel, and P. R. Fisher Diverse Cytopathologies in Mitochondrial Disease Are Caused by AMP-activated Protein Kinase Signaling Mol. Biol. Cell, May 1, 2007; 18(5): 1874 - 1886. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. E. Szmitko, H. Teoh, D. J. Stewart, and S. Verma Adiponectin and cardiovascular disease: state of the art? Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1655 - H1663. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Hopkins, N. Ouchi, R. Shibata, and K. Walsh Adiponectin actions in the cardiovascular system Cardiovasc Res, April 1, 2007; 74(1): 11 - 18. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Hattori, S. Hattori, K. Akimoto, T. Nishikimi, K. Suzuki, H. Matsuoka, and K. Kasai Globular Adiponectin Activates Nuclear Factor-{kappa}B and Activating Protein-1 and Enhances Angiotensin II-Induced Proliferation in Cardiac Fibroblasts Diabetes, March 1, 2007; 56(3): 804 - 808. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Han, M. J. Quon, J.-a Kim, and K. K. Koh Adiponectin and Cardiovascular Disease: Response to Therapeutic Interventions J. Am. Coll. Cardiol., February 6, 2007; 49(5): 531 - 538. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J Simons, P. S van den Pangaart, J. M F G Aerts, and L. Boon Pro-inflammatory delipidizing cytokines reduce adiponectin secretion from human adipocytes without affecting adiponectin oligomerization J. Endocrinol., February 1, 2007; 192(2): 289 - 299. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Wolk, P. Berger, R. J. Lennon, E. S. Brilakis, D. E. Davison, and V. K. Somers Association between plasma adiponectin levels and unstable coronary syndromes Eur. Heart J., February 1, 2007; 28(3): 292 - 298. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. A. Uchida, Y. Nakamura, M. Kaihara, H. Norii, Y. Hanayama, H. Sugiyama, Y. Maeshima, Y. Yamasaki, and H. Makino Steroid pulse therapy impaired endothelial function while increasing plasma high molecule adiponectin concentration in patients with IgA nephropathy Nephrol. Dial. Transplant., December 1, 2006; 21(12): 3475 - 3480. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Retnakaran, A. J.G. Hanley, and B. Zinman Does Hypoadiponectinemia Explain the Increased Risk of Diabetes and Cardiovascular Disease in South Asians? Diabetes Care, August 1, 2006; 29(8): 1950 - 1954. [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Nakano, S. Tajima, A. Yoshimi, H. Akiyama, M. Tsushima, T. Tanioka, T. Negoro, M. Tomita, and T. Tobe A novel enzyme-linked immunosorbent assay specific for high-molecular-weight adiponectin J. Lipid Res., July 1, 2006; 47(7): 1572 - 1582. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Aso, R. Yamamoto, S. Wakabayashi, T. Uchida, K. Takayanagi, K. Takebayashi, T. Okuno, T. Inoue, K. Node, T. Tobe, et al. Comparison of Serum High-Molecular Weight (HMW) Adiponectin With Total Adiponectin Concentrations in Type 2 Diabetic Patients With Coronary Artery Disease Using a Novel Enzyme-Linked Immunosorbent Assay to Detect HMW Adiponectin. Diabetes, July 1, 2006; 55(7): 1954 - 1960. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Wang, K. S. L. Lam, L. Chan, K. W. Chan, J. B. B. Lam, M. C. Lam, R. C. L. Hoo, W. W. N. Mak, G. J. S. Cooper, and A. Xu Post-translational Modifications of the Four Conserved Lysine Residues within the Collagenous Domain of Adiponectin Are Required for the Formation of Its High Molecular Weight Oligomeric Complex J. Biol. Chem., June 16, 2006; 281(24): 16391 - 16400. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Retnakaran, A. J.G. Hanley, P. W. Connelly, G. Maguire, M. Sermer, and B. Zinman Low Serum Levels of High-Molecular Weight Adiponectin in Indo-Asian Women During Pregnancy: Evidence of ethnic variation in adiponectin isoform distribution. Diabetes Care, June 1, 2006; 29(6): 1377 - 1379. [Full Text] [PDF]
|
|
|
|
|
|
R. Ouedraogo, X. Wu, S.-Q. Xu, L. Fuchsel, H. Motoshima, K. Mahadev, K. Hough, R. Scalia, and B. J. Goldstein Adiponectin Suppression of High-Glucose-Induced Reactive Oxygen Species in Vascular Endothelial Cells: Evidence for Involvement of a cAMP Signaling Pathway Diabetes, June 1, 2006; 55(6): 1840 - 1846. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Fujioka, K.-i. Kawabata, Y. Saito, T. Kobayashi, T. Nakamura, Y. Kodama, H. Takano, J.-e. Obata, Y. Kitta, K. Umetani, et al. Role of adiponectin receptors in endothelin-induced cellular hypertrophy in cultured cardiomyocytes and their expression in infarcted heart Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2409 - H2416. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Neumeier, J. Weigert, A. Schaffler, G. Wehrwein, U. Muller-Ladner, J. Scholmerich, C. Wrede, and C. Buechler Different effects of adiponectin isoforms in human monocytic cells J. Leukoc. Biol., April 1, 2006; 79(4): 803 - 808. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Hattori, S. Hattori, and K. Kasai Globular Adiponectin Activates Nuclear Factor-{kappa}B in Vascular Endothelial Cells, Which in Turn Induces Expression of Proinflammatory and Adhesion Molecule Genes Diabetes Care, January 1, 2006; 29(1): 139 - 141. [Full Text] [PDF]
|
|
|
|
|
|
C. Lara-Castro, N. Luo, P. Wallace, R. L. Klein, and W. T. Garvey Adiponectin Multimeric Complexes and the Metabolic Syndrome Trait Cluster Diabetes, January 1, 2006; 55(1): 249 - 259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Bobbert, H. Rochlitz, U. Wegewitz, S. Akpulat, K. Mai, M. O. Weickert, M. Mohlig, A. F.H. Pfeiffer, and J. Spranger Changes of Adiponectin Oligomer Composition by Moderate Weight Reduction Diabetes, September 1, 2005; 54(9): 2712 - 2719. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Isobe, S. Saitoh, S. Takagi, H. Takeuchi, Y. Chiba, N. Katoh, and K. Shimamoto Influence of gender, age and renal function on plasma adiponectin level: the Tanno and Sobetsu study Eur. J. Endocrinol., July 1, 2005; 153(1): 91 - 98. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Dietze-Schroeder, H. Sell, M. Uhlig, M. Koenen, and J. Eckel Autocrine Action of Adiponectin on Human Fat Cells Prevents the Release of Insulin Resistance-Inducing Factors Diabetes, July 1, 2005; 54(7): 2003 - 2011. [Abstract] [Full Text] [PDF]
|
|